What D56 covers · when clinicians use it
ICD-10 code D56 identifies Thalassemia in the U.S. ICD-10-CM clinical and billing record set. It sits within the Blood & Blood-forming Organs chapter (D50–D89), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply D56 when an encounter's findings match the Thalassemia description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify D56 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for D56 and is a coding reference, not clinical, diagnostic, or billing advice.
D56 refers to Thalassemia, a group of anemias characterized by the destruction of red blood cells (hemolysis) either due to genetic mutations or external/acquired factors. These conditions often require lifelong management and are associated with varying degrees of severity.
Symptoms
- Fatigue – Due to decreased oxygen delivery
- Jaundice – From bilirubin buildup following red cell breakdown
- Dark urine – Indicative of hemoglobinuria
- Pallor – From anemia
- Enlarged spleen – Common in hemolytic conditions
- Delayed growth – Especially in pediatric hereditary cases
- Bone deformities – Seen in thalassemia due to marrow expansion
Diagnosis
Diagnosis of Thalassemia includes complete blood count, reticulocyte count, peripheral smear, bilirubin levels, haptoglobin, LDH, hemoglobin electrophoresis, and genetic or enzymatic assays. Family history and clinical presentation also help differentiate between hereditary and acquired types.
ICD10 Code Usage
ICD10 code D56 is used in hematology and general practice to classify hemolytic anemias for diagnosis, treatment planning, insurance billing, and genetic counseling. It’s critical for monitoring disease progression and treatment efficacy.
Related Codes
- D55 – Anemia due to enzyme disorders
- D57 – Sickle-cell disorders
- D58 – Other hereditary hemolytic anemias
- D59 – Acquired hemolytic anemia
FAQs
Q1: What is ICD10 code D56?
A: It refers to Thalassemia, covering various hemolytic anemias, either inherited or acquired.
Q2: What causes these anemias?
A: Genetic mutations (e.g., G6PD deficiency, sickle cell, thalassemia) or acquired triggers like autoimmune disorders or certain drugs.
Q3: Are these lifelong conditions?
A: Most hereditary types are lifelong. Acquired forms may be temporary or chronic depending on the cause.
Q4: How are they managed?
A: Supportive care, transfusions, iron chelation, immunosuppressants, splenectomy, or bone marrow transplant in severe cases.
Q5: Who is at risk?
A: Individuals with family history or certain ethnic backgrounds (e.g., Mediterranean, African, Southeast Asian) are at higher risk for hereditary forms.
Conclusion
ICD10 code D56 plays an essential role in diagnosing and managing Thalassemia. It ensures appropriate medical documentation, helps track disease outcomes, and supports access to necessary treatments and follow-up care in patients with hemolytic anemia.